Zhejiang Tianyu Pharmaceutical: Current Market Snapshot and Recent Developments
Trading Performance
During the 24‑hour window concluding at 01:45 PM Central Europe on Friday, 23 March, the Shenzhen‑listed shares of Zhejiang Tianyu Pharmaceutical (ticker 300702.SZ) exhibited a neutral trading movement, registering a flat 0 % change. At the close, each share was priced at CNY 20.08 on the primary exchanges. The available liquidity is substantial, with 351.4 million shares circulating in the market. This figure translates into a market capitalization of CNY 7 billion. In the most recent 24‑hour period, a total of approximately CNY 63.6 million worth of shares changed hands, underscoring a modest yet steady trading volume.
Over the past month, the stock has declined by –8.04 % from its prior closing level, reflecting a broader downward trend. The 200‑day simple moving average stands at CNY 20.88, placing the current price slightly below its long‑term average. Historical reference points reveal a peak of CNY 27.80 reached on 14 November 2025, while the 52‑week low settled at CNY 17.98 on 4 June 2026.
Recent Corporate Action
In a bid to strengthen liquidity, Zhejiang Tianyu Pharmaceutical announced that its controlling shareholder has pledged several hundred thousand shares to refinance earlier loan obligations. This pledge represents a modest portion of the company’s equity base, mitigating the necessity for fresh borrowing and potentially improving the balance sheet’s stability. No further operational or financial disclosures were provided at the time of the announcement.
Peer Comparison (24‑Hour View)
| Stock | Ticker | 24‑h Change | Current Price | Market Cap | P/E Ratio |
|---|---|---|---|---|---|
| Jiangsu Seagull Cooling Tower | 603269.SS | 0 % | CNY 18.27 | CNY 8.3 bn | 67.42 |
| Dongguan Yutong Optical Te | 300790.SZ | 0 % | CNY 16.18 | CNY 8.3 bn | 41.55 |
| Ningbo Donly | 002164.SZ | 0 % | CNY 17.78 | CNY 8.3 bn | 41.13 |
| Hainan Drinda New Energy T | 2865.HK | –3.66 % | HKD 10.03 | HKD 9.7 bn | – |
| Visionox | 002387.SZ | 0 % | CNH 6.52 | CNH 9 bn | – |
The table illustrates that Zhejiang Tianyu’s contemporaries are largely trading flat or slightly downward, with the exception of Hainan Drinda, which saw a modest decline. The overall market sentiment appears cautious, aligning with the modest trading activity observed across these peers.
Company Profile
Founded in 1993, Zhejiang Tianyu Pharmaceutical Co., Ltd. operates within the pharmaceutical intermediates and active pharmaceutical ingredient (API) sector. Headquartered in Taizhou, China, the company engages in research, development, manufacturing, and sales of a diversified portfolio of products. Its expertise spans cardiovascular, anti‑diabetic, anti‑atherosclerotic, anticoagulant, and anti‑asthmatic intermediates and APIs. The firm is listed on the Shenzhen Stock Exchange under ticker 300702.SZ and maintains an online presence at www.tianyupharm.com .